gallimune se + st, water-in-oil emulsion for injection
boehringer ingelheim vetmedica gmbh - inactivated salmonella enteritidis pt4; inactivated salmonella typhimurium dt 104 - emulsion for injection - . - salmonella - chickens - immunological - inactivated vaccine
nobilis se live lyophilisate for use in drinking water for chickens
msd animal health uk limited - salmonella enteritidis - lyophilisate for use in drinking water - live bacterial vaccine - chickens
cevac salmovac lyophilisate for use in drinking water
ceva animal health ltd - salmonella enteritidis - lyophilisate for use in drinking water - live bacterial vaccine - chickens
cevac salmovac lyophilisate for use in drinking water
ceva animal health ltd - salmonella enteritidis - lyophilisate for use in drinking water - live bacterial vaccine - chickens
cevac salmovac lyophilisate for use in drinking water
ceva animal health ltd - salmonella enteritidis - lyophilisate for use in drinking water - live bacterial vaccine - chickens
avipro salmonella vac e lyophilisate for suspension
live attenuated salmonella enteritidis-bacteria, strain sm24/rif12/ssq - lyophilisate for suspension - 10 cfu
typhim vi- salmonella typhi ty2 vi polysaccharide antigen injection, solution
sanofi pasteur inc. - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r
vivotif-b capsule
rebel distributors corp - salmonella enterica subsp. enterica serovar typhi (unii: 760t5r8b3o) (salmonella enterica subsp. enterica serovar typhi - unii:760t5r8b3o) - salmonella enterica subsp. enterica serovar typhi 2 [cfu] - vivotif (typhoid vaccine live oral ty21a) is indicated for immunization of adults and children greater than 6 years of age against disease caused by salmonella typhi . routine typhoid vaccination is not recommended in the united states of america. selective immunization against typhoid fever is recommended for the following groups: 1) travelers to areas in which there is a recognized risk of exposure to s. typhi , 2) persons with intimate exposure (e.g. household contact) to a s. typhi carrier, and 3) microbiology laboratorians who work frequently with s. typhi (7). there is no evidence to support the use of typhoid vaccine to control common source outbreaks, disease following natural disasters or in persons attending rural summer camps. not all recipients of vivotif will be fully protected against typhoid fever. vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms. the vaccine will not afford protection against species of salmonella other than salmonella
pleo san salm- salmonella enterica subsp. enterica serovar enteritidis liquid
sanum kehlbeck gmbh & co. kg - salmonella enterica subsp. enterica serovar enteritidis (unii: y3v16d4pv4) (salmonella enterica subsp. enterica serovar enteritidis - unii:y3v16d4pv4) - salmonella enterica subsp. enterica serovar enteritidis 6 [hp_x] in 1 ml - for loss of appetite.
typhim vi- salmonella typhi ty2 vi polysaccharide antigen injection, solution
a-s medication solutions - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r